Introduction
Vocal fold medialization is performed as a treatment of vocal fold paralysis. Injection laryngoplasty is one of the techniques most widely used today as vocal fold medialization. The ideal injectable material would be biocompatible, nonreactive, nonvolatile, noncarcinogenic, easily injected, and would maintain its volume and position after injection. It is also clinically important to be easily prepared. Since injection laryngoplasty with paraffi n paste was fi rst reported by Wilhelm Brunings, a variety of injectable materials have been introduced. However, none of them have fulfi lled these criteria ideally. Tefl on had been the primary injectable material for almost 3 decades after Arnold [1] introduced its use in 1962, but it has now been abandoned because of widespread reports of foreign body reaction with granuloma formation [2] [3] [4] [5] . In Japan, silicone fl uid has been widely used until recently, because it is rarely absorbed and causes few foreign body reaction [6, 7] . However, because of reports of breast cancer [8] [9] [10] and human adjuvant disease [11, 12] after augmentation mammoplasty with silicone gel implants and the subsequent ban on the manufacturing and consignment of silicone implants enforced by the United States Food and Drug Administration in 1992, the use of silicone fl uid for augmentation mammoplasty has also been prohibited in Japan [13] . Thus, now in Japan, the only available injectable material, aside from autologous tissue, is atellocollagen. However, atellocollagen has disadvantages such as quick absorption, the need for repeat injection, and the potential of causing 'mad cow disease'. Autologous fat [14, 15] and fascia [16] are also absorbed and require time-consuming and complicated preparation. Calcium hydroxylapatite (CaHA) is a bioceramic compound of phosphate and calcium. Recently, CaHA has been introduced as an implant in the larynx and its biocompatibility has been demonstrated for clinical use. A prefabricated CaHA block has already been used for medialization thyroplasty [17] . For injection laryngoplasty, an injectable CaHA gel [18] [19] [20] began to be used more recently; this gel contains small spherules of CaHA suspended in an aqueous-based gel carrier.
Calcium phosphate cement (CPC, BIOPEX ® ; Mitsubishi Materials Corp., Tokyo, Japan) has been developed since 1989 and appeared in the market since 2000 [21, 22] . (In Europe and America, analogous products such as Bone Source ® [23, 24] and Norian SRS ® [25] [26] [27] are on the market.) A BIOPEX kit consists of powder and liquid, which become a paste upon mixing; this paste selfhardens and recrystallizes to CaHA in a living body. CPC is currently used in a wide variety of surgical settings, including orthopedic procedures and craniofacial reconstructions, for bone replacement and has been proven to be safe. It is also reported that when CPC was implanted even into soft tissue, mild infl ammatory reactions were seen focally with a small number of multinucleated giant cells and that microscopic resorption of the CPC implant was not clearly recognized [28] . Thus, CPC could be a new injectable material for injection laryngoplasty. Although injectable CaHA gel has already been used, the unique self-hardening characteristic of CPC may provide different advantages for injection laryngoplasty and investigating its utility seems worthwhile. In this study, to examine the suitability of CPC as an injectable material, the following evaluation was performed using rabbit models: (1) confi rmation of recrystallization from CPC to CaHA in the larynx; (2) volume and migration analyses; (3) histopathological examination for soft tissue reaction.
Materials and Methods
All animal experiments in this study were approved by the Institutional Animal Care and Use Committee of the Keio University School of Medicine.
Preparation of CPC
The CPC (BIOPEX; Mitsubishi Materials Corp.) used in this study was produced using a powder consisting of 75 wt% ␣ -tricalcium phosphate, 18 wt% tetracalcium phosphate, 5 wt% dicalcium phosphate dihydrate, 2 wt% hydroxyapatite, and a weakly basic hardening liquid consisting of 5 wt% sodium chondroitin sulfate, 12 wt% sodium succinate, and 83 wt% water. A powder/liquid weight ratio of 3.3 was used to permit easy injection using a tuberculin syringe while maintaining suffi cient strength.
The powder materials were dissolved in the liquid; the solution was mixed uniformly for 1 min and became a paste. The paste was injected within 4 min because it was starting to harden immediately. Fifteen minutes after mixing, the CPC was fully hardened and began recrystallizing to CaHA in the living body.
Injection Technique
Twelve New Zealand white rabbits (2.0-2.5 kg) were used for this study. The animals were sedated with an intramuscular combination of ketamine hydrochloride (35 mg/kg) and xylazine hydrochloride (5 mg/kg). A transverse skin incision was made, the strap muscles were incised in the midline and refl ected laterally, and the thyroid cartilage was exposed. The recurrent laryngeal nerve was identifi ed in the region of the paratrachea and sectioned on the left side. After vocal fold paralysis, CPC was immediately injected into the paraglottic space adjacent to the thyroarytenoid (TA) muscle, at the level of the vocal process via the thyroid cartilage, with an 18-gauge needle and a tuberculin syringe.
Confi rmation of Recrystallization from CPC to CaHA in the Larynx Using Scanning Electron Microscopy
CPC has a special characteristic of recrystallizing to CaHA in a living body. The aim of this scanning electron microscopy (SEM) observation is to investigate whether the injected CPC could be completely recrystallized to a CaHA block even in the larynx.
CPC was prepared and injected into the paraglottic space as mentioned above. Seven days after injection, the CPC blocks were removed from the larynges and fi xed in 70% ethanol solution. These were carefully stripped of the surrounding soft tissues, dried, and used for SEM analyses. The recrystallization state of the CPC injected into the larynx was compared with the control CPC using SEM (Hitachi S-4500, Tokyo, Japan). A control CPC was made by soaking in physiologic saline for 7 days.
Volume and Migration Analysis for Injected CPC At 1, 3, and 6 months, the larynges were excised. Whole larynges were fi xed in 10% formalin and decalcifi ed in Plank-Rychlo solution overnight. Then, each specimen was rinsed and processed using a paraffi n infi ltrator. The infi ltrated tissue was embedded in a paraffi n block and then serially sectioned through four or fi ve axial planes from the top to the bottom of the injected CPC. The remaining CPC volume percentage was determined by comparing the actual injection volume to the volume measured by microscopic analysis. The area of CPC present on each section was measured directly using a calibrated microscope eyepiece grid. The volume of remaining CPC was presumed to represent an ellipsoid and then calculated as previously reported [14, 16] . In addition, macrophotographs were taken at the level of the vocal fold process of the arytenoid cartilage.
Histopathological Examination for Soft Tissue Reaction to
Injected CPC At 1, 3, and 6 months, histopathological analysis of injected CPC was performed. The tissues were embedded in paraffi n, axially cut into 8-m slices, mounted on glass slides, and stained with hematoxylin and eosin. Once the histopathological analysis was completed, the infl ammatory response in the vocal fold tissue was microscopically graded by a single-blinded pathologist (K.K.) according to Mikus et al. [14] ( table 1 ) . Each specimen was graded by the average count of fi ve sections.
Results

Confi rmation of Recrystallization from CPC to
CaHA in the Larynx Using SEM If complete recrystallization from CPC to CaHA was achieved, CaHA-specifi c appearance such as tubular CaHA and needle-like CaHA would be observed in SEM fi ndings as shown in fi gure 1 a (control CPC). CPC injected into the vocal fold also showed tubular CaHA and needle-like CaHA ( fi g. 1 b), which was dense and formed a surface that was fl at and homogeneous. In addition, ␣ -tricalcium phosphate (unrecrystallization form) was not observed. These fi ndings indicated that the complete recrystallization from CPC to CaHA was achieved even in the larynx.
Volume and Migration Analysis for Injected CPC
In the macrophotographs, the CPC mass was easily identifi ed as a white block in the paraglottic space and the position was stable in all time periods observed ( fi g. 2 ).
The remaining CPC volume percentages are shown in table 2 . The average was 91.7% with a range of 83.3-97.5%. At 1 month (n = 4), the mean remaining volume was 90.2%; at 3 months (n = 3), it was 90.7%, and at 6 months (n = 3), it was 94.7%. 
Histopathological Examination for Soft Tissue
Reaction to Injected CPC At 1 month (n = 4), the representative section showed that the position of CPC was stable in the paraglottic space, thin fi brous encapsulation around CPC was observed ( fi g. 3 a), and multinucleated giant cells were rarely seen ( fi g. 3 b). However, in only one of four 1-month animals, the foreign body reaction was focally seen as a small number of multinucleated giant cells, histiocytes, and lymphocytes. Infl ammatory cell infi ltration in soft tissue around CPC 1 month after injection was graded as absent to moderate for each animal, as seen in table 3 .
At 3 months (n = 3), the representative section showed that the position of CPC was stable in the paraglottic space; fi brous encapsulation around CPC that was thicker when compared to that in 1-month animals was also observed ( fi g. 3 c). A focal aggregation of multinucleated giant cells adjacent to the TA muscle was observed ( fi g. 3 d). The infl ammatory level in the soft tissue around CPC 3 months after injection was graded as mild to moderate for each animal, as seen in table 3 . In addition, mature lamellar bone formation adjacent to thyroid cartilage was focally observed.
At 6 months (n = 3), the representative section showed fi brous encapsulation around CPC and osteogenesis with mature lamellar bone formation adjacent to thyroid cartilage ( fi g. 3 e), which appeared a little thicker when compared to that in 3-month animals ( fi g. 3 f). The degree of infl ammation was graded as moderate for each animal as seen in table 3 . The average was 91.7% with a range of 83.3-97.5%. At 1 month (n = 4), the mean remaining volume was 90.2%; at 3 months (n = 3), it was 90.7%, and at 6 months (n = 3), it was 94.7%. 
Discussion
It has been demonstrated that CaHA is biocompatible when implanted in the larynx. Cummings et al. [17] have already reported clinical experience with a prefabricated CaHA block for medialization thyroplasty and proved that there is limited acute infl ammatory response and rare foreign body giant cells in an in vivo study [29] . For injection laryngoplasty, CaHA must be in an injectable state. BIOPEX is CPC that becomes an easily injected paste when the powder materials and the liquid are mixed uniformly. Our study showed that after injection, CPC becomes self-hardening and recrystallizes to CaHA even in the larynx as shown by SEM. The average remaining CPC volume percentage was 91.7% with a range of 83.3-97.5%, which indicated that CPC was hardly absorbed in the larynx. The injectable CaHA gel used at present contains small spherules of CaHA suspended in an aqueousbased gel carrier; the gel carrier is absorbed and the CaHA spherules remain in the tissue. Chhetri et al. [18] performed a basic study using CaHA gel in a canine model. They reported that the gel carrier (70% in volume of the product) was absorbed. In addition, although the CaHA particle size was stable in all time periods in their study, the number of CaHA particles seemed to decrease after 3 months, which might mean absorption of the CaHA particles themselves. Rosen and Thekdi [19] have also reported that in a clinical 6-month observation period, overinjection was found to provide optimum results because of gel carrier absorption, indicating that each surgeon needs to develop his or her experience to predict the absorption. Because CPC is not absorbable, it does not require overinjection, which allows the performance of adequate vocal fold medialization. In this study, histopathological analysis of CPC injected into the vocal folds was performed. The infl ammatory response was microscopically graded in the same way as autologous fat injection described by Mikus et al. [14] ( table 1 ). Soft tissue reaction to injected CPC was limited to a foreign body reaction such as a small number of multinucleated giant cells, histiocytes, and lymphocytes. This result was similar to a soft tissue reaction to autologous fat injection [14] , which indicates that the biocompatibility of CPC is excellent when it is injected into soft tissue. In addition, mature lamellar bone formation adjacent to thyroid cartilage was focally observed at 3 and 6 months in this study. Flint et al. [29] have also reported that when a CaHA block was implanted for medialization thyroplasty, mature lamellar bone in the fenestra bridging the thyroid lamina and CaHA was observed at 12 months. This may be the result of an altered molecular environment where soft tissue interfaces with CPC or a common fi nding for CaHA left adjacent to cartilage tissue. Osteogenesis may result in CPC stabilization and limit the potential for migration or slippage of the CPC.
When we perform injection laryngoplasty using CPC, we need to pay attention to not inject it superfi cially because of its stiffness. If CPC is injected into the submucosal plane of the vocal fold, its stiffness will disturb the mucosal wave. Therefore, the ideal plane for CPC injection is the TA muscle or the area between the TA muscle and thyroid cartilage. There are some reports of disturbed mucosal wave in cases with the injectable CaHA gel. Chhetri et al. [18] mentioned in their canine model that the mucosal wave remained unaltered after injection of CaHA gel lateral to the TA muscle. Also Belafsky et al. [20] reported that they injected CaHA gel deep into the lateral portion of the TA muscle and strobovideolaryngoscopy revealed healthy-appearing vocal folds with normal mucosal wave in all individuals. Thus, CaHA gel must not be injected submucosally to preserve the mucosal wave. The difference between CPC and CaHA gel is stiffness and CPC is stiffer than conventional injectable materials such as Tefl on and silicone. Such stiffness is the same as the CaHA block for medialization thyroplasty; therefore, CPC may have strong pushing power and could be used as an injectable block. The special characteristic of CPC may widen the indication of injection laryngoplasty and injection laryngoplasty using CPC could be indicated for cases with a wide glottal gap.
This study revealed that CPC was biocompatible, nonabsorbable, and nonmigratory. We then commenced clin-ical application and have since performed several cases of injection laryngoplasty with CPC. Our limited clinical experience with CPC indicates that it is safe, nonabsorbable, and effective; however, the follow-up period for the earliest case is not much longer than 18 months. To confi rm the utility of CPC, a larger long-term study is needed.
Conclusion
We examined whether CPC could be used as an injectable material for vocal fold medialization using rabbit models. CPC appears to be biocompatible, nonabsorbable, nonmigratory, and suitable for injection laryngoplasty. The special characteristic of CPC is its stiffness due to self-hardening and recrystallization to CaHA and it would be used as an 'injectable CaHA block'. If CPC is injected into the submucosal plane of the vocal fold, its stiffness will disturb the mucosal wave, which is the disadvantage of CPC. However, this disadvantage will be overcome by injection into the TA muscle or the plane between the TA muscle and thyroid cartilage. On the other hand, the advantages of CPC are that it is rarely absorbed, it has minimal potential for slippage or migration, and it has strong pushing power like a CaHA block for medialization thyroplasty.
